DUBAI / WAM dnata, a global air and travel services provider, has deployed a fleet ...
Read More »EDD approves world’s first oral therapy for immune thrombocytopenia
ABU DHABI / WAM The Emirates Drug Establishment (EDE) has granted official approval for Rilzabrutinib, the first oral Bruton’s tyrosine kinase (BTK) inhibitor to be authorised in the country for the treatment of Immune Thrombocytopenia (ITP), a rare autoimmune disorder that affects approximately 2 to 5 individuals per 100,000 people worldwide. With this landmark approval, the UAE becomes the first ...
Read More »